Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

November 30, 2015 4:23 PM ET

Healthcare Equipment and Supplies

Company Overview of PharmaJet, Inc.

Company Overview

PharmaJet, Inc., a medical device company, develops and markets needle-free injection technology to deliver drugs and vaccines to intramuscular, subcutaneous, and intradermal tissue depths. The company offers PharmaJet Stratis, a needle-free injector which delivers liquid medications by means of a narrow fluid stream that penetrates the skin in about one-tenth of a second. It caters to individual patients and public health needs in the United States and internationally. PharmaJet, Inc. was incorporated in 2005 and is based in Golden, Colorado.

400 Corporate Circle

Suite N

Golden, CO 80401

United States

Founded in 2005





Key Executives for PharmaJet, Inc.

Chairman and Chief Executive Officer
Age: 59
President and Chief Operating officer
Age: 58
Founder, Advisor and Director
Chief Financial Officer
Design & Production Chief
Compensation as of Fiscal Year 2015.

PharmaJet, Inc. Key Developments

FDA Approves Use of AFLURIA Influenza Vaccine with PharmaJet, Inc.'s Needle-Free Injector

PharmaJet, Inc. announced the U.S. Food and Drug Administration (FDA) has approved the PharmaJet Stratis(R) 0.5mL Needle-Free Jet Injector for delivery of AFLURIA in individuals aged 18 to 64 years. This is the first needle-free delivery system approved by the FDA for the administration of an inactivated influenza vaccine. Needlestick injuries pose a serious risk to healthcare workers who administer vaccinations and manage sharps disposal. Among retail pharmacists alone, a National Institute for Occupational Safety and Health study reveals that the incidence of needlestick injury is up to 3.62 per 100,000 vaccinations administered. PharmaJet's needle-free injection technology eliminates needlestick injuries, needle re-use and potential cross contamination, as well as reduces sharps waste management and disposal costs.

Similar Private Companies By Industry

Company Name Region
Rio Grande Neurosciences Inc. United States
eyebobs, LLC United States
Zeal Optics, Inc. United States
Omni Surgical LP United States
Medlogics Device Corporation United States

Recent Private Companies Transactions

Private Placement
June 5, 2015
Private Placement
December 23, 2014

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact PharmaJet, Inc., please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at